| Direct oral anticoagulant dose selection: challenging cases S Carlin, JW Eikelboom Journal of Thrombosis and Haemostasis 19 (11), 2680-2686, 2021 | 10 | 2021 |
| Appropriateness of apixaban dosing to prevent stroke in patients with atrial fibrillation: a pilot study S Carlin, J Pickering, S Schulman The Canadian Journal of Hospital Pharmacy 69 (6), 449, 2016 | 10 | 2016 |
| Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances S Carlin, TAC de Vries, A Budaj, J Eikelboom Kardiologia Polska (Polish Heart Journal) 80 (12), 1200-1210, 2022 | 9 | 2022 |
| Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: a systematic review M Candeloro, S Carlin, MJ Shapiro, JD Douketis Research and Practice in Thrombosis and Haemostasis 7 (3), 100137, 2023 | 8 | 2023 |
| Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH S Carlin, A Cuker, A Gatt, N Gendron, V Hernández-Gea, K Meijer, ... Journal of Thrombosis and Haemostasis 22 (9), 2653-2669, 2024 | 4 | 2024 |
| Advances in anticoagulation: patients with bioprosthetic heart valves S Carlin, J Eikelboom Cardiovascular Research 118 (3), e26-e28, 2022 | 4 | 2022 |
| Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey S Carlin, A Bond, P Gross, A Bell, J Douketis, W Geerts, JP Galanaud Thrombosis Research 202, 176-181, 2021 | 3 | 2021 |
| Uncomplicated outpatient deep venous thrombosis management with a novel care pathway: Is it ready for prime time? A Godoy, S Carlin, JD Douketis European Journal of Internal Medicine 122, 40-41, 2024 | 1 | 2024 |
| Restarting anticoagulation after major bleeding in patients with atrial fibrillation. S Carlin, J Eikelboom The Canadian Journal of Cardiology, S0828-282X (24) 00019, 2024 | 1 | 2024 |
| Are P2Y12 inhibitors superior to aspirin for long-term secondary prevention of cardiovascular disease? S Carlin, J Eikelboom Expert Review of Cardiovascular Therapy 21 (5), 305-309, 2023 | 1 | 2023 |
| The ISTH SSC Subcommittee on Hemostatic Management of Patients with Liver Disease: goals, ambitions, and call for collaboration T Lisman, S Carlin, A Gatt, V Hernandez-Gea, JP Luyendyk, LN Roberts, ... Journal of Thrombosis and Haemostasis 21 (5), 1073-1074, 2023 | 1 | 2023 |
| Factor XI inhibition in cardiovascular disease. S Carlin, M Jakovac, A Budaj, J Eikelboom Polish Archives of Internal Medicine 134 (7-8), 16799-16799, 2024 | | 2024 |
| In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl level (vol 176, pg JC91, 2023) S Carlin ANNALS OF INTERNAL MEDICINE 176 (12), JC144-JC144, 2023 | | 2023 |
| Efficacy and Safety of Intensified vs Standard Prophylactic Anticoagulation Therapy in Patients Hospitalized With Coronavirus Disease 2019: Updated Systematic Review and Meta … TC Scheier, S Carlin, NK Wills, S Wasserman, D Mertz, JW Eikelboom Open Forum Infectious Diseases 10 (11), ofad506, 2023 | | 2023 |
| In healthy older adults, low-dose aspirin increased incident anemia at a median 4.7 y S Carlin, JW Eikelboom Annals of Internal Medicine 176 (10), JC115, 2023 | | 2023 |
| The ISTH SSC subcommittee on Hemostatic Management of Patients with Liver Disease: goals, ambitions, and call for collaboration: reply T Lisman, S Carlin, A Gatt, V Hernández-Gea, JP Luyendyk, LN Roberts, ... Journal of Thrombosis and Haemostasis 21 (9), 2632-2633, 2023 | | 2023 |
| In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl level S Carlin, J Douketis Annals of Internal Medicine 176 (8), JC91, 2023 | | 2023 |
| Routine measurement of DOAC concentrations for prognostication and clinical management in acute ischemic stroke: Is it ready for prime time? S Carlin, NC Chan, JD Douketis European Journal of Internal Medicine 113, 18-19, 2023 | | 2023 |
| Disordered Hemostasis and Renal Disorders S Rodriguez-Lopez, V Yiu, S Carlin, LR Brandão Pediatric Kidney Disease, 877-901, 2023 | | 2023 |
| Rivaroxaban Efficacy and Safety in SELECT-D Community Cancer-Associated Venous Thromboembolism Patients S Carlin, PL Gross Cardio Oncology 5 (2), 201-202, 2023 | | 2023 |